Ketamine tested as potential new weapon against meth addiction
NCT ID NCT06496750
Summary
This study is testing if ketamine, given through an IV, can help people with moderate to severe methamphetamine addiction reduce or stop their drug use. It will compare ketamine to another sedative drug (midazolam) in 120 adults over 12 weeks. Participants will receive eight IV infusions over six weeks along with weekly therapy sessions to see which treatment leads to more drug-free urine tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBSTANCE USE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Addiction Institute of Mount Sinai
TERMINATEDNew York, New York, 10029, United States
-
Interdisciplinary Substance Use and Brain Injury Facility
ACTIVE_NOT_RECRUITINGAlbuquerque, New Mexico, 87106, United States
-
Prisma Health
RECRUITINGGreenville, South Carolina, 29617, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75247, United States
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.